发明名称 |
IMPROVED CONTROLLED RELEASE ORAL DOSAGE FORM |
摘要 |
A pharmaceutical composition designed for once daily dosing of bupropion comprising: (A) a sustained release form of bupropion comprising: (i) a core comprising bupropion or a pharmaceutically acceptable salt or stereoisomer thereof, and (ii) a sustained release component, and (B) an immediate release form of bupropion or a pharmaceutically acceptable salt or stereoisomer thereof.
|
申请公布号 |
CA2796884(A1) |
申请公布日期 |
2002.08.15 |
申请号 |
CA20022796884 |
申请日期 |
2002.02.08 |
申请人 |
ANDRX PHARMACEUTICALS, INC. |
发明人 |
LI, BOYONG;CHEN, CHIH-MING;CHENG, XIU XIU;NANGIA, AVINASH |
分类号 |
A61K9/16;A61K9/00;A61K9/22;A61K9/50;A61K9/52;A61K31/00;A61K31/137;A61P25/24;A61P25/34 |
主分类号 |
A61K9/16 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|